Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Gynecologic Oncology
|
May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial
Mark H Stoler, Valentin Parvu, Karen Yanson, et al.
Gynecologic Oncology Reports
|
June 17, 2024
Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening
Laurence Vaughan, Devin Gary, Millie Shah, et al.
Gynecologic Oncology
|
March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay
Didier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology
|
April 24, 2018
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
Mark H Stoler, Thomas C Wright, Valentin Parvu, et al.
The Journal of Molecular Diagnostics : JMD
|
March 19, 2022
Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay
Stephanie Taylor, Agnieszka Rucki, Elizabeth Lockamy, et al.
American Journal of Clinical Pathology
|
December 3, 2020
Cotesting in Cervical Cancer Screening
Douglas P Malinowski, Molly Broache, Laurence Vaughan, et al.
International Journal of Cancer
|
March 22, 2019
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
Jesper Bonde, Fabio Bottari, Valentin Parvu, et al.
Journal of Clinical Microbiology
|
January 4, 2020
Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia
Eliane Rohner, Lisa Rahangdale, Busola Sanusi, et al.
Journal of Clinical Microbiology
|
October 22, 2020
Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus
Stephen Young, Laurence Vaughan, Karen Yanson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Gynecologic Oncology
|
May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial
Mark H Stoler, Valentin Parvu, Karen Yanson, et al.
Gynecologic Oncology Reports
|
June 17, 2024
Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening
Laurence Vaughan, Devin Gary, Millie Shah, et al.
Gynecologic Oncology
|
March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay
Didier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology
|
April 24, 2018
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results
Mark H Stoler, Thomas C Wright, Valentin Parvu, et al.
The Journal of Molecular Diagnostics : JMD
|
March 19, 2022
Validation of a New High-Throughput BD COR System Using the BD CTGCTV2 Assay
Stephanie Taylor, Agnieszka Rucki, Elizabeth Lockamy, et al.
American Journal of Clinical Pathology
|
December 3, 2020
Cotesting in Cervical Cancer Screening
Douglas P Malinowski, Molly Broache, Laurence Vaughan, et al.
International Journal of Cancer
|
March 22, 2019
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
Jesper Bonde, Fabio Bottari, Valentin Parvu, et al.
Journal of Clinical Microbiology
|
January 4, 2020
Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia
Eliane Rohner, Lisa Rahangdale, Busola Sanusi, et al.
Journal of Clinical Microbiology
|
October 22, 2020
Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus
Stephen Young, Laurence Vaughan, Karen Yanson, et al.
Page
of 1